Vitasora Health Ltd
Research Vitasora Health Ltd (VHL) on Bullrun: market cap AUD 28.18M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVHL
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyAUD
- Market capAUD 28.18M
- Financial periodFY2025
- RevenueAUD 3.09M
- Revenue growth577.1%
- Net income-AUD 10.11M
- Free cash flow-AUD 9.17M
- Gross margin99.0%
Valuation Snapshot
latest market cap is AUD 28.18M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | AUD 3.09M | -AUD 10.11M | -AUD 9.17M | 99.0% | -0.01 | AUD 394.24K | AUD 57.42K | AUD 14.67M |
| FY2024 | AUD 456.91K | -AUD 7.44M | -AUD 6.64M | 100.0% | -0.01 | AUD 762.87K | AUD 1.29M | AUD 2.59M |
| FY2023 | AUD 70.53K | -AUD 5.78M | -AUD 4.51M | 7.0% | -0.01 | AUD 146.16K | AUD 149.13K | AUD 826.89K |
| FY2022 | AUD 253.69K | -AUD 6.62M | -AUD 8.48M | -2.2% | -0.01 | AUD 1.22M | AUD 70.66K | AUD 3.01M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-27 | AUD 28.18M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Vitasora Health Ltd
Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Vitasora Health Ltd's market cap?
Vitasora Health Ltd's market capitalization is AUD 28.18M.
What does Vitasora Health Ltd do?
Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States. The company offers wheezo device. It is also involved in the production of mobile health applications. In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.